C16-PAF structure
|
Common Name | C16-PAF | ||
---|---|---|---|---|
CAS Number | 74389-68-7 | Molecular Weight | 523.683 | |
Density | N/A | Boiling Point | N/A | |
Molecular Formula | C26H54NO7P | Melting Point | N/A | |
MSDS | USA | Flash Point | N/A |
Use of C16-PAFC16-PAF is an endogenous platelet-activating factor (PAF) and ligand for PAF receptors. C16-PAF is produced by inflammatory cells and a potent chemoattractant for polymorphonuclear neutrophils. C16-PAF induces increased vascular permeability. |
Name | 2-O-acetyl-1-O-hexadecyl-sn-glycero-3-phosphocholine |
---|---|
Synonym | More Synonyms |
Description | C16-PAF is an endogenous platelet-activating factor (PAF) and ligand for PAF receptors. C16-PAF is produced by inflammatory cells and a potent chemoattractant for polymorphonuclear neutrophils. C16-PAF induces increased vascular permeability. |
---|---|
Target |
Human Endogenous Metabolite |
Molecular Formula | C26H54NO7P |
---|---|
Molecular Weight | 523.683 |
Exact Mass | 523.363770 |
PSA | 103.93000 |
LogP | 3.94 |
Appearance of Characters | lyophilized powder |
Storage condition | −20°C |
Hazard Codes | Xn: Harmful; |
---|---|
Risk Phrases | 22-38-40-48/20/22 |
Safety Phrases | 36/37-24/25-22 |
RIDADR | UN 1888 6.1/PG 3 |
WGK Germany | 3 |
RTECS | EC6060000 |
Precursor 9 | |
---|---|
DownStream 0 |
β-Acetyl-γ-O-hexadecyl-L-α-phosphatidylcholine |
PAF |
Platelet-activating factor |
[(2R)-2-acetyloxy-3-hexadecoxypropyl] 2-(trimethylazaniumyl)ethyl phosphate |
1-O-HEXADECYL-2-ACETYL-SN-GLYCERO-3-PHOSPHOCHOLINE |
2-O-acetyl-1-O-hexadecyl-sn-glycero-3-phosphocholine |
PAF Acether |
AcGEPC |
PAF(C16) |
MFCD00043214 |
(2R)-2-Acetoxy-3-(hexadecyloxy)propyl 2-(trimethylammonio)ethyl phosphate |
Ethanaminium, 2-[[[(2R)-2-(acetyloxy)-3-(hexadecyloxy)propoxy]hydroxyphosphinyl]oxy]-N,N,N-trimethyl-, inner salt |